Re:On the 100x Price Rise of a Formerly Generic Drug
by ramanujan on Tuesday March 15, 2011 @03:20AM
(#2326423)
Indeed. The genomics community is currently very angry at the FDA, as a senior official (CDRH director Jeffrey Shuren) appears to have been caught red handed lying under oath:
www.youtube.com/watch?v=YI-m2Cucdoo
His stated rationale is that increased FDA regulation against startups will help the"traditional manufacturers". No, really. Watch the whole thing.
www.youtube.com/watch?v=YI-m2Cucdoo
His stated rationale is that increased FDA regulation against startups will help the"traditional manufacturers". No, really. Watch the whole thing.